TRANSFORMING GLOBAL HEALTHCARE WITH TPET

 

Molecular Imaging Technology Inc. aims to create a substantial impact on global healthcare by addressing the critical issue of cancer detection and treatment. Our TPET technology is poised to redefine cancer screening by offering earlier diagnosis, which is essential for improving survival rates and outcomes for patients worldwide.

Molecular Imaging Technology Inc.
Molecular Imaging Technology Inc.

REVOLUTIONIZING CANCER SCREENING METHODS

 

As healthcare professionals and organizations strive to combat rising cancer rates, our innovative approach promises to be a game-changer in the fight against this disease. By significantly reducing radiation exposure while enhancing diagnostic capabilities, TPET has the potential to save lives and alleviate the burden on healthcare systems. To discuss how our technology can be integrated into your healthcare practices, please contact us.

 

SUMMARY OF SIGNIFICANT DEVELOPMENTS BY

UNITED STATES PATENT

PATENT NO.:
US 11,054,534,B1
DATE OF PATENT:
JULY 6, 2021

Molecular Imaging Technology Inc.